A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease

Preventing Chronic Disease

Volumn 11, Issue 5, 2014, Pages

  Oldenburg, Niki C ^a   Duval, Sue ^a   Luepker, Russell V ^a   Finnegan, John R ^a   LaMarre, Heather ^a   Peterson, Kevin A ^a   Zantek, Nicole D ^a   Jacobs, Ginny ^a   Straka, Robert J ^a   Miller, Karen H ^a   Hirsch, Alan T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; CARDIOVASCULAR DISEASES; COMMUNITY CARE; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROGRAM EVALUATION; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PRIMARY PREVENTION; PROGRAM EVALUATION;

EID: 84902096019     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd11.130378     Document Type: Article

References (33)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123(4): el8-209. CrossRef Pi PubMed B
2. Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 2010; 38(6): 600-9. CrossRef E PubMed B
3. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321(3): 129-35. CrossRef H PubMed B
4. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352(13) 1239-304. CrossRef E PubMed E
5. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT study group. Lancet 1998; 351(9118): 1755-62. CrossRef H. PubMed B
6. Thrombosis prevention trial: randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998; 351(9098): 233-41. CrossRef E PubMed 0
7. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295(3): 306-13. CrossRef B PubMed B
8. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2009; 150(6): 396-404. CrossRef E PubMed B
9. Healthy People 2020 objectives. http://healthypeople.gov/2020/topicsobjectives2020/ebr.aspx?topicid=2i. Accessed January 25, 2013.
10. Pearson TA, Blair SN, Daniels ST, Eckel RH, Fair JM, Fortmann SP, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002; 106(3): 388-91. CrossRef B PubMed El
11. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, et al. ADA/AHA/ACCF scientific statement: aspirin for primary prevention of cardiovascular events in people with diabetes. Circulation 2010; 121 (24)12694-701. CrossRef El PubMed H
12. Frieden TR, Berwick DM. The "Million Hearts" initiative - preventing heart attacks and strokes. N Engl J Med 2011: 365(13) : e27. CrossRef E PubMed B
13. Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med 2011; 124(7): 62l-9. CrossRef EJ PubMed B
14. Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172(3): 209-16. CrossRef B PubMed El
15. Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med 20l3; l59(2): 77-85. CrossRef P3 PubMed R
16. Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med 2007532(5) : 403-7. CrossRef S PubMed S
17. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among US adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 2006; 30(1): 74-7. CrossRef B PubMed B
18. VanWormer JJ, Greenlee RT, McBride PE, Peppard PE, Malecki KC, Che J, et al. Aspirin for primary prevention of CVD: are the right people using it? J Fam Pract 20l2; 6l(9): 525-32. PubMed H
19. Sanchez DR, Diez Roux AV, Michos ED, Blumenthal RS, Schreiner PJ, Burke GL, et al. Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol 2011; 107(1): 4l-6. CrossRef B PubMed B
20. Rodondi N, Vittinghoff E, Cornuz J, Butler J, Ding J, Satterfield S, et al. Aspirin use for the primary prevention of coronary heart disease in older adults. Am J Med 2005; 118(11): 1288. CrossRef R PubMed B
21. Luepker RV, Steffen LM, Duval S, Zhou X, Hirsch AT. Population trends in aspirin use for cardiovascular disease prevention 1980-2009. Eur Heart J 20l3; 34(Suppl 1): 473.
22. Sorensen G, Emmons K, Hunt MK, Johnston D. Implications of the results of community intervention trials. Annu Rev Public Health 1998; 19: 379-416. CrossRef B PubMed El
23. Papadakis S, Moroz I. Population-level interventions for coronary heart disease prevention: what have we learned since the North Karelia project? Curr Opin Cardiol 2008; 23(5): 452-61. CrossRef E PubMed E
24. Pennant M, Davenport C, Bayliss S, Greenheld W, Marshall T, Hyde C. Community program for the prevention of cardiovascular disease: a systematic review. Am J Epidemiol 2010; l72(5): 50l-l6. CrossRef B PubMed E
25. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011; (1): CDooi561. PubMed E
26. Community Preventive Services Task Force 2012 annual report to Congress and to agencies related to the work of the task force. http://www.thecommunityguide.org/annualreport/2012-congress-report-full.pdf. Accessed January 25, 2014.
27. US Census Bureau. American factfinder community facts: Hibbing, MN. 2010. http://factfinder2.census.gov/faces/nav/jsf/pages/community_facts.xhtml. Accessed September 19, 2013
28. Zantek ND, Luepker RV, Duval S, Miller K, Oldenburg N, Hirsch AT. Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement. Clin Appi Thromb Hemost 2013. CrossRef B PubMed E
29. Strully KW, Fowler JH, Murabito JM, Benjamin EJ, Levy D, Christakis NA. Aspirin use and cardiovascular events in social networks. Soc Sei Med 2012574(7) : 1125-9. CrossRef E PubMed B
30. Villablanca AC, Arline S, Lewis J, Raju S, Sanders S, Carrow S. Outcomes of national community organization cardiovascular prevention programs for high-risk women. J Cardiovasc Transl Res 2009; 2(3): 306-20. CrossRef m PubMed E
31. Eaton CB, Lapane KL, Garber CE, Gans KM, Lasater TM, Carleton RA. Effects of a community-based intervention on physical activity: the Pawtucket Heart Health Program. Am J Public Health l999; 89(11): l74l-4. CrossRef B PubMed M
32. Fortmann SP, Flora JA, Winkleby MA, Schooler C, Taylor CB, Farquhar JW. Community intervention trials: reflections on the Stanford Five-City Project. Am J Epidemiol l995; l42(6): 576-86. PubMed S
33. Institute of Medicine. Primary care and public health: exploring integration to improve population health. 2012. http://www.iom.edu/Reports/2012/Primary-Care-and-Public-Health.aspx. Accessed January 25, 2014